Evidence map›Paper›PMID 33799339›Full record

ArticleInternational journal of molecular sciences2021

Genetic Deletion of Trace-Amine Associated Receptor 9 (TAAR9) in Rats Leads to Decreased Blood Cholesterol Levels.

Ramilya Z Murtazina, Ilya S Zhukov, Olga M Korenkova, Elena A Popova, Savelii R Kuvarzin, Evgeniya V Efimova, Larisa G Kubarskaya, Ekaterina G Batotsyrenova, Ekaterina A Zolotoverkhaya, Anastasia N Vaganova and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Ramilya Z MurtazinaInstitute of Translational Biomedicine, Saint Petersburg State University, Universitetskaya nab., 7-9, 199034 Saint Petersburg, Russia.ORCID 0000-0001-5746-2204
Ilya S ZhukovInstitute of Translational Biomedicine, Saint Petersburg State University, Universitetskaya nab., 7-9, 199034 Saint Petersburg, Russia.
Olga M KorenkovaInstitute of Translational Biomedicine, Saint Petersburg State University, Universitetskaya nab., 7-9, 199034 Saint Petersburg, Russia.
Elena A PopovaMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Roessle-str. 10, 13125 Berlin, Germany.
Savelii R KuvarzinInstitute of Translational Biomedicine, Saint Petersburg State University, Universitetskaya nab., 7-9, 199034 Saint Petersburg, Russia.ORCID 0000-0002-9456-4717
Evgeniya V EfimovaInstitute of Translational Biomedicine, Saint Petersburg State University, Universitetskaya nab., 7-9, 199034 Saint Petersburg, Russia.ORCID 0000-0002-9641-515X
Larisa G KubarskayaInstitute of Toxicology of Federal Medical-Biological Agency, Bekhtereva str. 1, 192019 Saint Petersburg, Russia.
Ekaterina G BatotsyrenovaInstitute of Toxicology of Federal Medical-Biological Agency, Bekhtereva str. 1, 192019 Saint Petersburg, Russia.
Ekaterina A ZolotoverkhayaInstitute of Toxicology of Federal Medical-Biological Agency, Bekhtereva str. 1, 192019 Saint Petersburg, Russia.
Anastasia N VaganovaInstitute of Translational Biomedicine, Saint Petersburg State University, Universitetskaya nab., 7-9, 199034 Saint Petersburg, Russia.ORCID 0000-0002-0101-1065
Sergey A ApryatinInstitute of Translational Biomedicine, Saint Petersburg State University, Universitetskaya nab., 7-9, 199034 Saint Petersburg, Russia.
Natalia V AleninaInstitute of Translational Biomedicine, Saint Petersburg State University, Universitetskaya nab., 7-9, 199034 Saint Petersburg, Russia.ORCID 0000-0002-6071-5433
Raul R GainetdinovInstitute of Translational Biomedicine, Saint Petersburg State University, Universitetskaya nab., 7-9, 199034 Saint Petersburg, Russia.
St Petersburg University · RUFederal Medical-Biological Agency · RUMax Delbrück Center · DE

Funding

Russian Foundation for Basic Research 20-34-90099Russian Science Foundation 19-75-30008
6 · The paper itself

Abstract

In the last two decades, interest has grown significantly in the investigation of the role of trace amines and their receptors in mammalian physiology and pathology. Trace amine-associated receptor 9 (TAAR9) is one of the least studied members of this receptor family with unidentified endogenous ligands and an unknown role in the central nervous system and periphery. In this study, we generated two new TAAR9 knockout (TAAR9-KO) rat strains by CRISPR-Cas9 technology as in vivo models to evaluate the role of TAAR9 in mammalian physiology. In these mutant rats, we performed a comparative analysis of a number of hematological and biochemical parameters in the blood. Particularly, we carried out a complete blood count, erythrocyte osmotic fragility test, and screening of a panel of basic biochemical parameters. No significant alterations in any of the hematological and most biochemical parameters were found between mutant and WT rats. However, biochemical studies revealed a significant decrease in total and low-density lipoprotein cholesterol levels in the blood of both strains of TAAR9-KO rats. Such role of TAAR9 in cholesterol regulation not only brings a new understanding of mechanisms and biological pathways of lipid exchange but also provides a new potential drug target for disorders involving cholesterol-related pathology, such as atherosclerosis.

Indexed as

AnimalsAtherosclerosisCentral Nervous SystemCholesterolCRISPR-Cas SystemsDisease Models, AnimalErythrocytesGene Knockout TechniquesHumansLigandsOsmotic FragilityRatsReceptors, G-Protein-CoupledTrace Amine-Associated ReceptorsCholesterolLigandsReceptors, G-Protein-CoupledTrace Amine-Associated Receptorsanimal knockout modelcholesterolGPCRlow-density lipoproteinTAARTAAR9trace amine-associated receptortrace amines

Identifiers

PMID33799339
PMCPMC7998418
OpenAlexW3136612688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.